纯能P2X7受体作为抑郁症潜在治疗点
Wang Qi1, Xiang Jin2, Wei Guan3
1Department of Pharmacology, The First People's Hospital of Yancheng, Yancheng 224000, Jiangsu, China.
Biochemical pharmacology
|December 5, 2023
概括
P2X7受体 (P2X7R) 是一种ATP通道,与抑郁症有关. 抑制P2X7R显示抗抑郁作用,表明它是抑郁症的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 抑郁症的发病包括复杂的机制.
- P2X7受体 (P2X7R) 是一种由ATP引入的离子通道,存在于脑组织中,并影响与抑郁症相关的病理学.
- 对于P2X7R在抑郁症中的确切作用尚不清楚.
研究的目的:
- 审查纯能P2X7受体在抑郁症中的作用.
- 探索P2X7R作为潜在的抑郁症治疗点.
- 总结最近关于P2X7R和抑郁症的发现.
主要方法:
- 来自谷歌学者和PubMed (过去5年) 的研究文献综述.
- 对P2X7R功能特征的分析.
- 对P2X7R抑制和抗抑郁作用研究的审查.
- 针对P2X7R治疗抑郁症的药物的概述.
主要成果:
- 过度的P2X7R激活会增加炎症性细胞因子的释放,导致抑郁症.
- 抑制P2X7R在动物模型中表现出类似抗抑郁药的效果.
- P2X7R信号传递会调解类似抑郁症的行为.
- 通过调节P2X7R表达,一些药物表现出抗抑郁作用.
结论:
- 纯能P2X7受体是抑郁症神经病理学中的一个重要因素.
- P2X7R代表了新型抑郁症治疗的有前途的治疗标.
- 对P2X7R调节的进一步研究可能会导致有效的抗抑郁药物治疗.
相关概念视频
G-protein Coupled Receptors
119.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
119.6K
G Protein-coupled Receptors
12.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.1K
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
Depression: Overview
252
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
252
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K


